Food Allergy Collaborative members support comments to FDA to improve its Q&As about food allergens and labeling
Led by FARE (Food Allergy Research & Education), all FAC members and additional organizations supported detailed comments to FDA to improve its Q&As about food allergens and food allergen labeling
Click here to download the comments
January 30, 2023
Many Food Allergy Collaborative members support comments to FDA about intentional addition of sesame and control of PAL statements
Led by AAFA (Asthma and Allergy Foundation of America), many FAC members and additional organizations supported comments to FDA about intentional addition of sesame to bakery products and need to control and regulate use of precautionary allergen labeling (PAL) statements
Click here to download the comments
January 30, 2023
Racial Disparities Found in Food Allergy Anaphylaxis Awareness, Education
Healio Medical news outlet highlights research done by FAC surrounding racial disparities in food allergy anaphylaxis and education
December 21, 2022
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto-Injector
SnackSafely.com article features research presented by FAC at annual AAAAI meeting related to epinepheline access and use among food allergic adults
November 10, 2022
Food Allergy Collaborative Releases Voice of the Patient Report
Announcing the release of the Voice of the Patient Report, the summarizing document resulting from the Patient-Focused Drug Development meeting for food allergies held in September 2021
October 20, 2022
Food Allergy Collaborative comments submitted to the 2022 White House Conference on Hunger, Nutrition, and Health
FAC addressed needs of the food allergy community to be integrated into the national strategy generated from the September 2022 White House Conference on Hunger, Nutrition, and Health
Click here to download the report
July 22, 2022
Food Allergy Patients and Parents Report Challenges of Managing Disease to FDA
At Externally-led Patient-Focused Drug Development Meeting, More Than 40 Advocates Ask for Better Diagnosis, More Treatments, and Diversity and Inclusion During Testing
September 10, 2021